The epithelial lining of the gastrointestinal tract performs a demanding balancing act. A single cellular layer must withstand stomach acid, digestive enzymes, bile salts, and microbes while absorbing essential nutrients and blocking toxins from systemic circulation. When this mucosal barrier weakens—triggered by stress, non-steroidal anti-inflammatory drugs (NSAIDs), alcohol, strenuous exercise, or dysbiosis—the result is mucosal irritation and elevated intestinal permeability, widely termed “leaky gut.”
In response, gastroenterology researchers have focused on a targeted chelate: zinc-L-carnosine (known clinically as polaprezinc). Unlike standard zinc supplements that dissociate immediately in gastric juice, zinc carnosine adheres to damaged tissues, releasing its components where repair is needed. Below is an evidence-based review of its mechanisms, clinical trials, and safety considerations.
What Is Zinc-L-Carnosine?
Zinc-L-carnosine is a chelated compound composed of elemental zinc bound in a 1:1 ratio with L-carnosine, a dipeptide of beta-alanine and L-histidine. Developed in Japan, it was approved as a prescription drug (Promac) in 1994 for gastric ulcers and gastritis. In the United States and Europe, it is sold as a dietary supplement under brand names such as PepZin GI.
Its primary advantage is chemical stability. Conventional zinc salts (such as zinc sulfate or gluconate) dissociate quickly in stomach acid, releasing free zinc ions that often trigger nausea while providing minimal localized mucosal support. By contrast, zinc-L-carnosine features a polymeric structure that dissolves very slowly. This allows the intact chelate to adhere electrostatically to ulcerated or inflamed mucosal surfaces, creating a sustained local reservoir of zinc and carnosine directly at injury sites.
How Zinc Carnosine Strengthens the Mucosal Barrier
Laboratory and clinical investigations demonstrate that zinc-L-carnosine acts via several complementary pathways:
- Stabilizing Tight Junctions: The gut barrier relies on tight junctions—primarily zonula occludens-1 (ZO-1) and occludin—to seal spaces between adjacent epithelial cells. Research indicates zinc carnosine upregulates ZO-1 and occludin expression, limiting paracellular leakage of macromolecules and endotoxins.
- Accelerating Epithelial Restitution: When the mucosal lining is injured, surviving cells must rapidly migrate across the denuded basement membrane to restore barrier continuity. In vitro assays show that zinc carnosine stimulates epithelial cell migration and wound closure in a dose-dependent manner.
- Inducing Heat Shock Proteins: Polaprezinc stimulates the local expression of cytoprotective chaperones, including heat shock protein 70 (HSP70) and HSP27, which defend cells against oxidative and chemical stress.
- Suppressing Local Inflammation: Both zinc and carnosine scavenge reactive oxygen species. In addition, the compound downregulates nuclear factor-kappa B (NF-κB) signaling, curbing proinflammatory cytokines such as interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α).
Clinical Trial Evidence in Humans
Human randomized controlled trials have examined zinc carnosine across several specific gastrointestinal conditions.
1. Mitigating NSAID-Induced Gut Injury
NSAIDs frequently induce gastric and small intestinal damage by suppressing protective prostaglandins. In a randomized crossover trial published in Gut, Professor Raymond J. Playford and colleagues (Mahmood et al., 2007) evaluated 10 healthy human volunteers across multiple treatment arms.
Participants received indomethacin (50 mg three times daily) to provoke gut injury, with or without zinc carnosine (37.5 mg twice daily). Intestinal permeability was measured using the lactulose:rhamnose excretion ratio. Indomethacin alone induced a threefold increase in permeability (the ratio rose from 0.35 to 1.05). However, co-administration of zinc carnosine prevented this rise, preserving small-bowel integrity. Limitations included the small sample (n=10) and brief duration, though parallel animal models confirmed marked reductions in gastric injury.
2. Truncating Exercise-Induced Intestinal Permeability
Strenuous endurance training shunts blood away from the gut, causing transient ischemia and a two- to threefold increase in mucosal permeability. In a double-blind, randomized crossover trial published in the American Journal of Clinical Nutrition (Davison et al., 2016), investigators tested active male volunteers undergoing intense treadmill running in hot conditions.
Participants received zinc carnosine (37.5 mg twice daily) or placebo for 14 days before an exercise challenge. Zinc carnosine supplementation truncated the exercise-induced surge in gut permeability by approximately 70% compared to placebo. Co-administration with bovine colostrum offered protective benefits after just two days, demonstrating rapid barrier stabilization.
3. Gastric Ulcers, Gastritis, and H. Pylori Support
In a systematic review in Integrative Medicine (Hewlings and Kalman, 2020), clinical trials in Japan involving over 600 patients showed that polaprezinc achieved 60% to 75% endoscopic ulcer healing within 8 weeks, matching standard cytoprotective drugs like cetraxate. Furthermore, clinical trials by Kashimura et al. in Alimentary Pharmacology & Therapeutics showed that adding polaprezinc to triple therapy for Helicobacter pylori improved eradication rates and decreased mucosal inflammation compared to antibiotics alone.
Zinc Carnosine vs. Standard Zinc Salts
Standard zinc supplements differ substantially from zinc-L-carnosine in chemistry and pharmacokinetics:
| Parameter | Zinc-L-Carnosine (Polaprezinc) | Standard Zinc Salts (Sulfate, Gluconate) |
|---|---|---|
| Chemical Form | Stable 1:1 polymeric chelate of zinc and L-carnosine | Ionic salts that dissociate rapidly into free ions |
| Gastric Transit | Dissolves slowly; adheres to injured mucosa | Rapid dissociation; clears quickly from stomach |
| Mucosal Repair | High; stimulates epithelial restitution and ZO-1 | Minimal direct mucosal adherence or local action |
| Typical Daily Dose | 75–150 mg complex (16–32 mg elemental zinc) | 15–50 mg elemental zinc |
| Digestive Tolerance | Generally soothing; well tolerated | Frequently causes nausea on an empty stomach |
Source: Clinical and pharmacological data compiled from Mahmood et al. (Gut, 2007), Davison et al. (Am J Clin Nutr, 2016), and Hewlings & Kalman (Integr Med, 2020).
Dosage, Safety, and Mineral Balance
Clinical trials typically administer 75 mg to 150 mg of zinc-L-carnosine daily, split into two doses. Because the compound is roughly 21.5% elemental zinc by weight, 75 mg provides about 16 mg of elemental zinc, while 150 mg yields 32 mg.
The National Institutes of Health (NIH) Office of Dietary Supplements defines the Tolerable Upper Intake Level (UL) for zinc in adults at 40 mg daily from all sources. Taking 150 mg of zinc carnosine approaches this limit when dietary intake from food is added. Chronic zinc excess stimulates intestinal metallothionein, which traps copper and can cause secondary copper deficiency, anemia, and neurological issues. Therefore, individuals using zinc carnosine for more than a few weeks should monitor total zinc intake, ensure adequate dietary copper, and consult their healthcare provider.
Important Evidence Limitations
While findings are promising, zinc carnosine has defined boundaries:
- Requires Time: Endoscopic healing in clinical trials required 4 to 12 weeks of daily supplementation. It is not an instant fix for acute distress.
- Not a Substitute for Diagnostic Care: Alarming symptoms—such as unexplained weight loss, persistent vomiting, or rectal bleeding—require comprehensive medical evaluation rather than self-directed supplementation.
- Lifestyle Factors Matter: Supplementation cannot offset continuous mucosal damage caused by heavy alcohol consumption, severe unmanaged stress, or excessive NSAID misuse.
Related Reading
- Zinc: The Mineral for Immunity, Healing, and Hormones
- Zinc-Induced Copper Deficiency: Why High Zinc Causes Anemia
- Leaky Gut? Plant Compounds That Strengthen Your Barrier
- Butyrate and Gut Health: What Research Shows About SCFAs
Sources and Further Reading
- Mahmood A, FitzGerald AJ, Marchbank T, et al. Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes. Gut. 2007;56(2):168-175. doi:10.1136/gut.2006.099929.
- Davison G, Marchbank T, March DS, Thatcher R, Playford RJ. Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers. The American Journal of Clinical Nutrition. 2016;104(2):526-536. doi:10.3945/ajcn.116.134403.
- Hewlings S, Kalman D. A Review of Zinc-L-Carnosine and Its Clinical Efficacy in Gastrointestinal Diseases. Integrative Medicine (Encinitas). 2020;19(1):20-24. PMCID: PMC7227169.
- Kashimura H, Matsuoka T, Suzuki M, et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxicillin and clarithromycin increases the cure rate of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 1999;13(4):483-487. doi:10.1046/j.1365-2036.1999.00494.x.
Disclosure: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.